Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society - 1 May 2010

Batra Jyotsna, Tan Olivia L, O'Mara Tracy, Zammit Rebecca, Nagle Christina M, Clements Judith A, Kedda Mary-Anne, Spurdle Amanda B

Abstract excerpt

INTRODUCTION: Kallikrein-related peptidase 10 (KLK10) overexpression is a predictor of poor disease outcome in women with late-stage ovarian cancer. We aimed to identify whether KLK10 overexpression could be attributed to genetic variants, in particular, in hormone response elements or transcription factor binding sites. METHODS: Cox regression analysis was used to assess the association between 2 tag and 1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Clear Cell
Share to Adenocarcinoma, Mucinous

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystadenocarcinoma, Serous

Share to Endometrial Neoplasms

Share to Estrogens

Share to Kallikreins

Share to Progesterone

Share to Response Elements

Source

Identifiers

PMID: 20686372
DOI: 10.1111/IGC.0b013e3181d9273e

Genes

KLK10

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival.PMID 20686372Read ↗

Kallikrein-related peptidase 3 (KLK3/PSA) single nucleotide polymorphisms and ovarian cancer survival.Semantic proximity Read ↗

An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian CarcinomaSemantic proximity Read ↗

Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancerSemantic proximity Read ↗

Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.Semantic proximity Read ↗

Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.Semantic proximity Read ↗

Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 – KLK9), using Next-generation sequencingSemantic proximity Read ↗

A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival.Semantic proximity Read ↗

Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers.Semantic proximity Read ↗

Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.Semantic proximity Read ↗

Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impactSemantic proximity Read ↗

Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancerSemantic proximity Read ↗

Survival prediction based on inherited gene variation analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.